Zinzino AB Series B
Research Zinzino AB Series B (ZZ-B) on Bullrun: valuation model: 10.5% undervalued, market cap SEK 5.23B, P/E 13.7, dividend yield 4.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerZZ-B
- ExchangeST
- CountrySweden
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencySEK
- Valuation signal10.5% undervalued
- Market capSEK 5.23B
- P/E13.7
- Dividend yield4.5%
- Financial periodQ4 2025
- RevenueSEK 1.04B
- Net incomeSEK 123.62M
- Free cash flowSEK 270.04M
- Gross margin35.8%
Valuation Snapshot
Bullrun's latest valuation model marks Zinzino AB Series B as 10.5% undervalued; latest market cap is SEK 5.23B; P/E is 13.7; dividend yield is 4.5%.
About Zinzino AB Series B
Zinzino AB (publ), a direct sales company, provides dietary supplements and skincare products in Sweden and internationally. The company operates through two segments, Zinzino and Faun. It offers skincare products including cleansers, face creams, serums, and masks. The company provides coffee, coffee machines, accessories, and cups; immune, omega, and restored supplements; weight management products; gut health supplements; and home health test products. It also sells its products online.
Frequently asked questions
Is Zinzino AB Series B overvalued or undervalued?
Bullrun's valuation model currently marks Zinzino AB Series B as 10.5% undervalued.
What is Zinzino AB Series B's market cap?
Zinzino AB Series B's market capitalization is SEK 5.23B.
What is Zinzino AB Series B's P/E ratio?
Zinzino AB Series B's price-to-earnings (P/E) ratio is 13.7.
Does Zinzino AB Series B pay a dividend?
Zinzino AB Series B has a dividend yield of 4.5%.
What does Zinzino AB Series B do?
Zinzino AB (publ), a direct sales company, provides dietary supplements and skincare products in Sweden and internationally. The company operates through two segments, Zinzino and Faun. It offers skincare products including cleansers, face creams, serums, and masks.